<DOC>
	<DOC>NCT00583089</DOC>
	<brief_summary>To gather data and analyze decompensation events.</brief_summary>
	<brief_title>Decompensation Detection Study</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<criteria>Patients implanted with an approved Guidant CRTD HF device programmed to CRT therapy in VDD or DDD mode. Patients prescribed to the LATITUDE(R) system configured for at least weekly device interrogations and symptoms reporting. Patients willing to use the LATITUDE(R) enabled weight scale. Patients that require adaptive rate pacing (rateresponsive modes). Patients that have received routinely scheduled intravenous inotropic therapy as part of their drug regimen within the past 90 days. Both</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>